The BMJ Formula

an easy way to effectively support

bone, joints, connective tissue and

neuromuscular function.

The BMJ provides multiple nutrients in a very bioavailable form with benefits documented by research.

Bone
Included is a patented dicalcium malate for improved calcium bioavailability. See comparison graph. (Blue-Dicalcium Malate, Red-Calcium Carbonate)

Excerpted and summarized from the full study entitled “Comparison of calcium Absorption from various calcium- containing products in Healthy Human Adults: A Bioavailability study”. Copyrights, Albion International, Inc. November, 2005

Calcium is important, but it is not necessary to take high amounts according to research. When a two year study compared perimenopausal women who took either 1000 mg or 2000 mg of calcium daily with a placebo group, the groups taking calcium increased their bone density by 1.6%. No difference was found between the groups taking 1000 mg or 2000 mg indicating there is no reason to take high amounts (Elders PJ, et al. 1994).

Bone also needs other important nutrients. Magnesium has shown to prevent fractures and increase bone density (Sojka JE, Weaver CM. 1995, Stendig-Lindberg G, et al. 1993).

Bone density has been found to be significantly better when the minerals zinc, copper, manganese, and potassium were added to calcium (Strause L, et al. 1994). Zinc intake and plasma zinc concentrations have been documented to be lower in men with osteoporosis, this has also been reported for women (Hyun TH, et al. 2004).

Minerals in the form of amino acid chelates have documented better bioavailability when compared with other forms of minerals. As an example, when an amino acid chelate of zinc was compared with zinc gluconate, the amino acid chelate increased the bioavailability of zinc by 43.4% (Gandia P, et al. 2007).

Magnesium, copper, zinc and manganese are included in the BMJ as patented amino acid chelates.

Vitamin D is important for many reasons and it is very common to be deficient or marginally deficient in this vitamin. Vitamin D has been documented to reduce the fracture risk in elderly persons (Bischoff-Ferrari HA, et al. 2009, Bischoff-Ferrari HA, et al. 2005).

Vitamin D3 (cholecalciferol) is more efficient in sustaining vitamin D levels. Vitamin D2 potency is less than one third that of vitamin D3 and has much shorter duration of action compared to vitamin D3 (Armas LA, et al. 2004).

The graph below shows research comparing glucosamine sulfate with Ibuprofen for eight weeks (Vaz AL. 1982).

After four weeks the glucosamine sulfate produced more pain relief than the Ibuprofen.

Two studies conducted over three years documented that cartilage degeneration stopped in the treatment group taking glucoseamine sulfate while the control group experienced further degeneration (Reginster JY. 2001, Pavelka K, et al. 2002).
Research has documented that glucoseamine sulfate supplies cartilage with building materials. Glucosamine sulfate caused a significant stimulation of proteoglycan production by chondrocytes (cartilage cells) in samples obtained from human osteoarthritic cartilage (Basleer C, et al, 1998).
Another study showed that treatment of osteoarthritic chondrocytes with glucosamine sulfate resulted in an increased cell-mediated GAG (glycosaminoglycans) content (Dodge GR, Jimenez SA, 2003). GAG is a common building block both for cartilage, ligaments, and tendons.

Free radicals are also a factor involved in cartilage degeneration. Patients with osteoarthritis had approximately a four fold lower level of extra cellular SOD, the body’s own antioxidant enzymes a constituent of cartilage (Regan E, et al. 2005).

Zinc, copper, and manganese are necessary for the formation of SOD. That is one of the reasons these minerals are included in the BMJ.

Vitamin D is also important for joints. An increased risk for osteoarthritis of the hip and knee has been documented in people with low risk levels of vitamin D (Bergink AP, et al. 2009, Lane NE, et al. 1999). Osteoarthritis of the knee and hip progress more rapidly in patients with low vitamin D (McAlindon TE, et al. 1996, Lane NE, et al. 1999).

A high percentage of patients with non-traumatic persistent, musculoskeletal pain have been found to be vitamin D deficient (Plotnikoff GA, et al. 2003).

Research also shows that support of bone metabolism is important for cartilage integrity. Higher baseline serum osteocalcin, a marker of bone metabolism, has been found to be associated with a decreased rate of cartilage loss (Wang Y, et al. 2005).

The BMJ includes important nutrients for both bone and joint metabolism.

Coach Harry Marra – National Director World’s Greatest Athlete Decathlon Club,USA :

“Training for the decathlon is a 7 day a week, year round regiment, spanning every aspect of physical development…Strength, speed, explosive power, aerobic endurance, coordination/skill acquisition, flexibility and mental training…It is inevitable that the body can not stand up to this type of daily grind without some parts becoming sore and inflamed. One injury and 4 years of training for the Olympic Games goes right down the drain. Since the late 1990’s, we have relied on the formula BMJ to assist our athletes in warding off these nagging aches and pains, especially in their joint areas, and I can without reservation say that formula BMJ has made a difference in our athletes preparation. Additionally, it has helped speed the recovery time from a demanding training session, so that the athletes were better prepared for their next practice. I have been involved in the sport of track and field and decathlon specifically since 1961...Everyone out there knows and understands my stance on performance enhancing supplements...I have been against them since day 1! Formula BMJ is a safe way to assist your body to feel better over the long run. I continue to work out myself, and get those aches and pains like everyone else…Formula BMJ has helped me get back to the jogging paths more consistently. I recommend it fully.”

References:

Armas LA, et al. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004 Nov;89(11):5387-91.

Basleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage. 1998 Nov;6(6):427-34.

D’Ambrosio E, Casa B, Bompani R, et al. Glucosamine sulphate: a controlled clinical investigation in arthrosis. Pharmatherapeutica 1981;2:504.

da Camara CC, Dowless GV. Glucoseamine sulfate for osteoarthritis. Ann Pharmacother, 1998; 32:580-87.

Dodge GR, Jimenez SA. Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthritis Cartilage. 2003 Jun;11(6):424-32.

Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of glucoseamine sulfate in osteoarthritis; a placebo controlled double–blind investigation. Clin Ther, 1980; 3:260-72.

Elders, PJ, et al. Long term effect of calcium supplementation on bone loss in perimenopausal women. J Bone Min Res, 1994; 9:963-70.

Foster-Powell K, Miller JB. International tables of glycemic index. Am J Clin Nutr, 1995;62:871-93.

Gandia P, Bour D, Maurette JM, Donazzolo Y, Duchène P, Béjot M, Houin G. A bioavailability study comparing two oral formulations containing zinc (Zn bis-glycinate vs. Zn gluconate) after a single administration to twelve healthy female volunteers. Int J Vitam Nutr Res. 2007 Jul;77(4):243-8.

Gershoff SN, Prien EL. Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones. Am J Clin Nutr. 1967 May;20(5):393-9.

Hyun TH, et al. Zinc intakes and plasma concentrations in men with osteoporosis: the Rancho Bernardo Study. Am J Clin Nutr. 2004 Sep;80(3):715-21.

Lane NE, Gore LR, et al. Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Arthritis Rheum. 1999;42(5):854-860.

McAlindon TE, Felson DT, et al. Relationship of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med. 1996;125(5):353-359.

Pavelka K, Gatterova J, et al. Glucoseamine sulfate use and delay of progression of knee osteoarthritis. A 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med, 2002; 162:2113-23.

Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003;78(12):1463-1470.

Prien E, Gershoff S, Magnesium Oxide-Pyridoxine Therapy for recurrent Calcium Oxalate Calculi. J. Urol. 1974:112:509-512.

Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral Glucosamine sulphate in the basic treatment of osteoarthrosis. Curr Med Res Opin 1980; 7:110.

Regan E, Flannelly J, et al. Extracellular superoxide dismutase and oxidant damage in osteoarthritis. Arthritis Rheum. 2005 Nov;52(11):3479-91.

Reginster JY, et al. Long-term effects of glucoseamine sulfate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet. 2001:357:251-256.

Sojka JE, Weaver CM. Magnesium supplementation and osteoporosis. Nutr Rev. 1995 Mar;53(3):71-4.

Stendig-Lindberg G, et al. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res. 1993 Jun;6(2):155-63.

Strause L, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr. 1994 Jul;124(7):1060-4.

Lopes VA. Double-blind clinical evaluation of the relative efficacy of ibuprofen and Glucosamine sulphate in the management of osteoarthrosis of the knee in outpatients. Curr Med Res Opin 1982;8:145.

Wang Y, Ebeling PR, Hana F, et al. Relationship between bone markers and knee cartilage volume in healthy men. J Rheumatol. 2005 Nov;32(11):2200-4.